Michael Joffre is a director in Sterne Kessler’s Trial & Appellate Practice Group. Mike is co-chair of the firm’s appellate practice and focuses on intellectual property disputes before trial and appellate courts. He has argued and won cases throughout the country, including in Texas, California, Wisconsin, Delaware, New Jersey, the U.S. International Trade Commission (ITC), the U.S. Patent Trial and Appeal Board (PTAB), and the Federal Circuit. He has also represented clients before the U.S. Supreme Court at both the certiorari and merits stages.

Mike is a skilled litigator, adept at handling cases involving a variety of technologies and products, including microprocessors, telecommunications networks, mechanical devices, consumer products, and computer software. He also draws on his strong scientific background to counsel pharmaceutical companies on matters related to Abbreviated New Drug Applications (ANDAs).

Prior to entering law school, Mike worked as a research scientist in cosmology at the University of Chicago and Fermilab. Following law school, he served as a law clerk for Judge William C. Bryson, U.S. Court of Appeals for the Federal Circuit, 2004-2005. He received his J.D. from Harvard Law School, a Ph.D. from the University of Chicago, and a B.S. from the Massachusetts Institute of Technology.

  • Limelight Networks Inc. v. Akamai Techs., Inc., No. 12-786 (U.S. Sup. Ct. 2014) (Represented Limelight; obtained reversal of Federal Circuit decision, which had dramatically broadened the law of indirect infringement.)
  • St. Clair Intellectual Property Consultants, Inc. v. Toshiba America Inc., No. 16-1355 (Fed. Cir. 2016) (Represented St. Clair; obtained summary affirmance on appeal that case was not exceptional)
  • Certain Audio Processing Hardware and Software and Products Containing Same, Inv. No. 337-TA-949 (U.S.I.T.C. 2016) (Represented Dell; defended Dell against claims of infringement and was the first party ever to successfully seek use of the ITC’s 90-day pilot program; then, obtained favorable settlement on eve of hearing.)
  • Stragent, LLC v. Intel Corp., No. 6:11-cv-421-TBD-JDL (E.D. Tex. 2014) (Represented Stragent; acted as appellate counsel during district court trial to ensure all matters of law were correctly preserved; successfully defended against claims that the case was exceptional.)
  • Ricoh Co., Ltd. v. Quanta Computer, Inc., No. 06-cv-462-bbc (W.D. Wis. 2010) (Representing Ricoh; obtained reversal on appeal of unfavorable summary judgment ruling in patent infringement case brought by Ricoh against Taiwanese maker of optical disc drives; then, on remand, obtained $14.5 million jury verdict for patentee.)

  • Patexia, “Best-Performing Patent Litigators Representing Plaintiffs (Top 100)” (2023)
  • Managing IP, “IP Star” (2023 – 2020)
  • IAM Patent 1000, “Washington, DC: Patent Litigation (Bronze Band)” (2023 – 2018)
  • Super Lawyers, “Super Lawyers – Washington DC” (2023 – 2022)
  • Patexia, “100 Most Active CAFC Attorneys Representing Patent Appellants (Top 50)” (2021)
  • Patexia, “100 Most Active CAFC Attorneys Overall (Representing Appellants and Appellees) (Top 50)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellees (Top 50)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellants (Top 10)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Overall (Representing Appellants or Appellees) (Top 10)” (2021)

  • J.D., Harvard Law School, magna cum laude
  • Ph.D., Astrophysics, University of Chicago
  • B.S., Physics, Massachusetts Institute of Technology

  • District of Columbia
  • Massachusetts
  • Supreme Court of the United States
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the First Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the District of Massachusetts

  • U.S. Court of Appeals for the Federal Circuit

Webinar

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions

Virtual, January 23, 2024 1:00 PM - 2:00 PM EST

Webinar

ENCORE: Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Virtual, February 16, 2023 1:00 PM - 2:00 PM EST

Webinar

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Virtual, February 2, 2023 1:00 PM - 2:00 PM EST

Webinar

An Expert Guide to Appeals: U.S. Court of Appeals for the Federal Circuit [Boardroom]

Virtual, April 28, 2022 9:00 AM - 10:00 AM EST

Webinar

Preparing for PTAB and US ITC Appeals and Potential Litigation Processes

Virtual, April 14, 2022 11:00 AM - 12:00 PM EST

Speaking Engagement

2020 Bench & Bar® Virtual Conference

Virtual Conference, June 17, 2020 4:45 PM - 5:45 PM EST

Webinar

Divided Infringement Since Akamai En Banc: Development of the Law

March 14, 2017 12:00 AM - 7:59 PM EST

Related Resources

From Michael Joffre, Ph.D.

Firm Announcements

April 2, 2024

Sterne Kessler Secures PTAB Win on Behalf of Client RoboticVISIONTech

Sterne, Kessler, Goldstein & Fox

Bylined Articles

January 24, 2024

SNIPR Technologies Ltd. v. Rockefeller University, 72 F.4th 1372 (Fed. Cir. 2023) (Chen, Wallach, Hughes)

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Bylined Articles

January 24, 2024

In re Cellect, LLC, 81 F.4th 1216 (Fed. Cir. 2023) (Lourie, Dyk, Reyna)

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Bylined Articles

January 24, 2024

Introduction (Federal Circuit IP Appeals: Summaries of Key 2023 Decisions)

Sterne, Kessler, Goldstein & Fox William H. Milliken, Michael Joffre, Ph.D.

Press Release

January 24, 2024

Sterne Kessler Publishes Federal Circuit IP Appeals: Summaries of Key 2023 Decisions Report

Sterne, Kessler, Goldstein & Fox William H. Milliken, Michael Joffre, Ph.D.

Webinar Recordings & Materials

January 23, 2024

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions

William H. Milliken, Michael Joffre, Ph.D.

Reports

January 22, 2024

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions (8th Edition)

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 4, 2024

Victory in the courtroom: Sweegen's Victory Redefines Stevia Sweetener

Korea IT Times Multiple Authors

Firm Announcements

January 3, 2024

Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 2, 2024

Fed. Circ. Backs Calif. Decision Invalidating Sweetener IP

Law360 Multiple Authors

Press Release

July 6, 2023

Sterne Kessler and 14 Directors Earn Top Rankings in Managing IP’s 2023 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

June 26, 2023

Firm and 18 Sterne Kessler Directors Earn Top Rankings in 2023 IAM Patent 1000 for World-Class Patent Work

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

June 2, 2023

What Practitioners Need to Know About Patent Invalidity at the Federal Circuit

IAM Multiple Authors

Client Alert

May 18, 2023

Supreme Court Affirms Federal Circuit’s Decision in Amgen v. Sanofi

William H. Milliken, Michael Joffre, Ph.D.

Webinar Recordings & Materials

February 16, 2023

ENCORE: Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

William H. Milliken, Michael Joffre, Ph.D.

Press Release

February 7, 2023

Sterne Kessler Publishes Report Examining Key 2022 Federal Circuit Rulings on PTAB and ITC Appeals

Sterne, Kessler, Goldstein & Fox William H. Milliken, Michael Joffre, Ph.D.

Bylined Articles

February 6, 2023

Introduction – Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Webinar Recordings & Materials

February 2, 2023

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Michael Joffre, Ph.D.

In the News

December 1, 2022

Patexia Insight 161: Top CAFC Law Firms of 2022

Patexia Michael Joffre, Ph.D.

Press Release

November 21, 2022

Sterne Kessler and Its Attorneys Ranked Highly for Appellate Practice in Patexia’s 2022 CAFC Intelligence Report

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

September 12, 2022

Korean Co. Can't Be First To Invent CRISPR, PTAB Told

Law360 Michael Joffre, Ph.D.

Press Release

September 9, 2022

Sterne Kessler Wins Hatch-Waxman Impact Case of the Year Award at 2022 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Press Release

July 12, 2022

Sterne Kessler and 17 Directors Distinguished for Excellence in Patent Litigation and Prosecution in 2022 IAM Patent 1000

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Press Release

July 5, 2022

Sterne Kessler and 14 Directors Earn Top Rankings for IP Litigation and Prosecution in Managing IP’s 2022 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

May 25, 2022

Tastes Like Invalidity—Judge Knocks Out Sweetener Patents, Despite PTAB Ruling

The Recorder Michael Joffre, Ph.D.

Firm Announcements

May 25, 2022

Sterne Kessler Team Secures Summary Judgment of Patent Invalidity on Behalf of Sweegen, Inc. in District Court

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

May 24, 2022

Stevia Patent Claims Fall After SweeGen Challenge

Law360 Michael Joffre, Ph.D.

In the News

May 24, 2022

Sweegen Wins Challenges to Rival’s Artificial Sweetener Patents

Bloomberg Law Michael Joffre, Ph.D.

In the News

May 6, 2022

Fed. Circ. Rejects Narcan Maker's Redo Bid In Patent Suit

Law360 Michael Joffre, Ph.D.

Press Release

May 1, 2022

Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

April 19, 2022

Fed. Circ. Revives Rovi Patent That Comcast Got PTAB To Ax

Law360 Michael Joffre, Ph.D.

In the News

March 25, 2022

ImmunoGen Wins New Chance To Receive Patent on Ovarian Cancer Treatment

Reuters Michael Joffre, Ph.D.

In the News

March 25, 2022

Fed. Circ. Revives ImmunoGen's Cancer Treatment Patent App

Law360 Michael Joffre, Ph.D.

In the News

March 25, 2022

ImmunoGen Patent Application Suit Sent Back to Court (1)

Bloomberg Law Michael Joffre, Ph.D.

In the News

March 8, 2022

Sens. Cruz, Lee Brief High Court in Vet's Disability Denial Row

Law360 Michael Joffre, Ph.D.

In the News

February 18, 2022

Litigator of the Week Runners-Up and Shout Outs

Law.com Michael Joffre, Ph.D.

In the News

February 11, 2022

Federal Circuit Tosses Naloxone Patents

Law Street Media Michael Joffre, Ph.D.

In the News

February 10, 2022

Teva Win Invalidating Narcan Patents Upheld by Federal Circuit

Bloomberg Law Michael Joffre, Ph.D.

In the News

February 10, 2022

Court Affirms Teva Win in Fight Over Generic Narcan Anti-Overdose Drug

Reuters Michael Joffre, Ph.D.

In the News

February 10, 2022

Split Fed. Circ. Won't Restore 4 Narcan Patents

Law360 Michael Joffre, Ph.D.

Press Release

February 7, 2022

Sterne Kessler Releases Report Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Reports

February 3, 2022

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

February 3, 2022

Introduction – Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

February 3, 2022

Minerva Surgical, Inc. v. Hologic, Inc., 141 S. Ct. 2298 (2021)

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Bylined Articles

February 3, 2022

Uniloc 2017 LLC v. Facebook Inc., 989 F.3d 1018 (Fed. Cir. 2021)

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

September 7, 2021

AbbVie Settles Patent Dispute Over Muscle Stimulation Tech

Law360 Michael Joffre, Ph.D.

Press Release

July 26, 2021

Sterne, Kessler, Goldstein & Fox Earns 13 Market-Leading Awards for Excellence in the First Six Months of 2021

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Press Release

July 1, 2021

Sterne, Kessler, Goldstein & Fox and 16 Directors Recognized for Excellence in 2021 IAM Patent 1000 Rankings

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Client Alert

June 29, 2021

What You Should Know About the Supreme Court's Decision in Minerva

William H. Milliken

Press Release

June 17, 2021

Sterne Kessler and 13 Directors Earn Top Rankings for IP Litigation and Prosecution in 2021 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox William H. Milliken

In the News

March 15, 2021

Federal Circuit Backs Caterpillar Rival's Patent Win

Law360 William H. Milliken

Client Alert

February 26, 2021

Arthrex SCOTUS Oral Arguments on Monday! We'll Be Live Tweeting Updates

William H. Milliken

Press Release

January 27, 2021

Sterne Kessler Publishes New Report “Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions”

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

January 26, 2021

Introduction -- Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

December 18, 2020

Fed. Circ. Agrees That Caterpillar ITC Patent Claim Is Invalid

Law360 Michael Joffre, Ph.D.

In the News

November 3, 2020

Justices Skip Case Horizon Said Puts 32K Patents At Risk

Law360 Michael Joffre, Ph.D.

Client Alert

October 14, 2020

Five Things to Know About the Supreme Court’s Grant of Certiorari in Arthrex

William H. Milliken

Press Release

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C. William H. Milliken

In the News

October 1, 2020

Teva Unit Tells High Court Not To Take Up Horizon's IP Loss

Law360 William H. Milliken

In the News

July 31, 2020

Teva Gets Fed. Circ. to Affirm Thyroid Patent is Indefinite

Law360 William H. Milliken

In the News

June 29, 2020

Top 6 Patent Rulings Of 2020: A Midyear Report

Law360 William H. Milliken

In the News

June 23, 2020

Obviousness Doomed Narcan Patents After NJ Bench Trial

Law360 William H. Milliken

Press Release

June 16, 2020

Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000

Sterne, Kessler, Goldstein & Fox P.L.L.C. William H. Milliken

In the News

June 5, 2020

Teva Invalidates Opiant Patents In Narcan Suit

Law360 William H. Milliken

In the News

May 19, 2020

CIT Clears Wirtgen Imports Over CBP's Patent Objections

Law360 William H. Milliken

Press Release

May 5, 2020

Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property

Sterne, Kessler, Goldstein & Fox P.L.L.C. William H. Milliken

Client Alert

April 21, 2020

Supreme Court Holds That PTAB Time-Bar Rulings Are Non-Appealable

William H. Milliken

Bylined Articles

March 23, 2020

Open Issues After Fed. Circ. PTAB Judge Appointments Ruling

Law360 Michael Joffre, Ph.D., William H. Milliken

Press Release

March 17, 2020

Sterne Kessler Publishes Two Reports -- PTAB Year in Review and Federal Circuit Appeals from the PTAB

Sterne, Kessler, Goldstein & Fox P.L.L.C. Michael Joffre, Ph.D., William H. Milliken

In the News

February 20, 2020

Rival Says Allergan Muscle Toner Not As Strong As Claimed

Law360 Michael Joffre, Ph.D., William H. Milliken

Client Alert

February 3, 2020

IP Hot Topic: Federal Circuit Appeals from the PTAB: Summaries of Key 2019 Decisions

Michael Joffre, Ph.D.

Press Release

February 3, 2020

Sterne, Kessler, Goldstein & Fox Summarizes Key Decisions in 2019 Federal Circuit Appeals From The PTAB Report

Sterne, Kessler, Goldstein & Fox P.L.L.C. Michael Joffre, Ph.D.

Reports

January 24, 2020

Federal Circuit Appeals From The PTAB: Summaries of Key 2019 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

January 24, 2020

Papst Licensing GMBH & Co. v. Samsung Elec. Am., Inc., 924 F.3d 1243 (Fed. Cir. 2019)

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

In the News

January 8, 2020

Supreme Court Ruling on Patent Board Appeals May Have Ripple Effect

Bloomberg Law Michael Joffre, Ph.D.

In the News

December 5, 2019

High Court To Scrutinize Appeals Of PTAB Time-Bar Decisions

Law360 Michael Joffre, Ph.D.

Bylined Articles

November 14, 2019

Fed. Circ.’s Arthrex Ruling: Unforeseen Consequences For IPR

Law360 Multiple Authors

In the News

September 30, 2019

PTAB Cuts Down Two More Allergan Restasis Patents

Law360 Multiple Authors

In the News

July 23, 2019

Caterpillar Hit With Import Ban In Latest Round Of ITC Battle

Law360 Multiple Authors

Firm Announcements

July 10, 2019

Sterne Kessler Succeeds in Receiving an En Banc Decision in United States of America v. Riley Briones, Jr., AKA Unknown Spitz

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

June 13, 2019

Fed. Circ. Expanded Patent Law's Reach, Enplas Tells Justices

Law360 Multiple Authors

Press Release

June 12, 2019

Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000"

Sterne, Kessler, Goldstein & Fox P.L.L.C Multiple Authors

In the News

June 3, 2019

Supreme Court Refuses 'Blocking Patent' Rule Case

Law360 Multiple Authors

In the News

May 24, 2019

Fed. Circ. Backs Samsung, Apple In Interface Patent Fight

Law360 Multiple Authors

In the News

April 22, 2019

Caterpillar Can't Ax Road Milling Machine Patent At ITC

Law360 Multiple Authors

Press Release

April 8, 2019

Sterne Kessler Earns Recognition for “Impact” Litigation Case and Patent Prosecution at 2019 Managing Intellectual Property Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

April 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360 Multiple Authors

Bylined Articles

March 18, 2019

Biopharma Patent Applicants Should Consider a Rarely Used Strategy

Bloomberg Law Multiple Authors

In the News

March 7, 2019

Justices Urged To Turn Down PTAB Tribal Immunity Case

Law360 Multiple Authors

In the News

March 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360 Multiple Authors

In the News

February 15, 2019

Restasis Patent Redo Bid 'Inappropriate,' Fed. Circ. Told

Law360 Multiple Authors

In the News

January 22, 2019

Fed. Circ. Affirms Toshiba Win Over LCD Screen IP Suit

Law360 Multiple Authors

In the News

December 17, 2018

The Biggest Patent Cases of 2018

Law360 Multiple Authors

In the News

December 12, 2018

Fed. Circ. OKs Teva's Patent Win Over Allergan Colitis Drug

Law360 Multiple Authors

In the News

December 6, 2018

Fed. Circ. Questions Allergan On Water's Role In Colitis Patent

Law360 Multiple Authors

In the News

November 19, 2018

Fed. Circ. Erases Seoul Semiconductor's $4M Patent Award

Law360 Multiple Authors

In the News

November 13, 2018

Fed. Circ. Won't Restore Allergan's Restasis Patent Claims

Law360 Multiple Authors

In the News

November 6, 2018

Fed. Circ. Urged Not to Stay Immunity Ruling for Appeal

Law360 Multiple Authors

In the News

October 31, 2018

Allergan, Generic Cos. Battle Over Restasis Launch Plans

Law360 Multiple Authors

In the News

October 26, 2018

Allergan, Tribe Want IPRs Blocked As They Turn To High Court

Law360 Multiple Authors

In the News

October 22, 2018

Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing

Law360 Multiple Authors

Bylined Articles

October 19, 2018

Inventor's Case Highlights Appeal Option For Rejected Patent

Law360 Multiple Authors

In the News

September 19, 2018

No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears

Law360 Multiple Authors

In the News

September 7, 2018

States Back Tribe, Allergan Fed. Circ. Bid For PTAB Immunity

Law360 Multiple Authors

In the News

September 4, 2018

Generics Cos. Urge Fed. Circ. To Upend Depomed Patent Win

Law360 Multiple Authors

In the News

August 20, 2018

Allergan, Tribe Want PTAB Immunity Denial Reheard En Banc

Law360 Multiple Authors

In the News

July 20, 2018

Fed. Circ. Says Tribal Immunity Doesn't Apply In IPR

Law360 Multiple Authors

In the News

April 24, 2018

AIA Reviews Survive High Court, But Future Challenges Likely

Law360 Multiple Authors

In the News

March 26, 2018

Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs

Law360 Multiple Authors

Presentations

March 9, 2018

Global IP Strategy Conference 2018 PowerPoint Presentations

Multiple Authors

In the News

March 8, 2018

Don't Revive Restasis Patents, Generic Cos. Urge Fed. Circ.

Law360 Multiple Authors

Reports

March 1, 2018

2018 Report: Federal Circuit Appeals from the PTAB - Summaries of Key 2017 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

December 5, 2017

Prison Phone Rivals Reach Confidential Deal in IP Row

Law360 Multiple Authors

Bylined Articles

September 13, 2017

PTAB At 5: Part 3 — Fed. Circ. Statistics

Law360 Multiple Authors

In the News

June 16, 2017

What To Do Until Justices Resolve AIA Constitutionality

Law360 Multiple Authors

Client Alert

June 12, 2017

Supreme Court to Review the Constitutionality of AIA Patent Review Proceedings

Multiple Authors

In the News

June 6, 2017

Appealing PTAB Loss, IV Finds Tough Crowd at Fed. Circ.

Law360 Multiple Authors

In the News

January 30, 2017

Sterne Kessler Adds 2 Kellogg Huber IP Pros as Directors

Law360 Multiple Authors

In the News

January 29, 2017

Washington-Area Appointments and Promotions for Jan. 30

The Washington Post Multiple Authors

In the News

January 26, 2017

Sterne, Kessler, Goldstein & Fox Adds Directors

World Intellectual Property Review Multiple Authors

Press Release

January 25, 2017

Litigators J.C. Rozendaal and Mike Joffre Join Sterne Kessler

Multiple Authors